stars 1 stars 2 stars 3

Verda Bio seeks to bring scientific expertise to product formulation and dosing of cannabinoid based therapeutics (CBTs). At Verda Bio, we are performing research on CBTs using the latest scientific technology to perform genomic, analytical, and clinical research on CBTs. At Verda Bio, genomic and analytical data will serve as the backbone for CBT development. By combining analytical chemistry, technology, and genomic data, Verda Bio will be able to control for the variability in many cannabis strains and create CBTs (cannabinoid based therapeutics) that selectively and consistently meet the needs of specific patient populations.

Verda Bio Questions

The Verda Bio annual revenue was $202000 in 2026.

Nolan Scheible is the Director of Plant Research of Verda Bio.

2 people are employed at Verda Bio.

Verda Bio is based in Seattle, Washington.

The NAICS codes for Verda Bio are [54, 541713, 5417, 54171, 541].

The SIC codes for Verda Bio are [87, 873].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users